Michael Penn
Vice President, Intellectual Property
Bluerock Therapeutics
Mike is the Vice President of Intellectual Property at BlueRock Therapeutics, a clinical-stage wholly owned subsidiary of Bayer with a focus on stem cell therapeutics to treat disease in the areas of neurology, ophthalmology, cardiology, and immunology. Mike has over 30 years of experience in the biotech, pharmaceutical industry, and diagnostics industries, where he spent nearly a decade as a bench scientist before making the change to a career in intellectual property law. Mike started his IP career at the USPTO as an Examiner, spent several years in private practice at Sterne Kessler, and worked for large and small innovator companies including MedImmune, AstraZeneca, and Amgen prior to joining BlueRock.
mpenn@bluerocktx.com